Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 41 | $7,155,469 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
20 Sep 2024 16:55 | CNTA | Centessa Pharmaceuticals plc | SAHA SAURABH | Chief Executive Officer | 20 Sep 2024 | Sale | 55,000 | 16.527 | 908,985 | D |
12 Sep 2024 20:01 | CNTA | Centessa Pharmaceuticals plc | WEINHOFF GREGORY M | Chief Business Officer | 10 Sep 2024 | Sale | 30,000 | 17 | 510,000 | D |
12 Sep 2024 20:01 | CNTA | Centessa Pharmaceuticals plc | SAHA SAURABH | Chief Executive Officer | 10 Sep 2024 | Sale | 175,000 | 16.5247 | 2,891,822 | D |
09 Sep 2024 17:06 | CNTA | Centessa Pharmaceuticals plc | WEINHOFF GREGORY M | Chief Business Officer | 09 Sep 2024 | Sale | 25,000 | 15 | 375,000 | D |
23 Aug 2024 17:13 | CNTA | Centessa Pharmaceuticals plc | SAHA SAURABH | Chief Executive Officer | 23 Aug 2024 | Sale | 46,651 | 12.3021 | 573,905 | D |
23 Aug 2024 17:12 | CNTA | Centessa Pharmaceuticals plc | WEINHOFF GREGORY M | Chief Business Officer | 22 Aug 2024 | Sale | 12,198 | 12.1684 | 148,430 | D |
23 Aug 2024 17:12 | CNTA | Centessa Pharmaceuticals plc | WEINHOFF GREGORY M | Chief Business Officer | 23 Aug 2024 | Sale | 17,802 | 12.2903 | 218,792 | D |
22 Aug 2024 17:15 | CNTA | Centessa Pharmaceuticals plc | SAHA SAURABH | Chief Executive Officer | 22 Aug 2024 | Sale | 506 | 12.23 | 6,188 | D |
22 Aug 2024 17:15 | CNTA | Centessa Pharmaceuticals plc | SAHA SAURABH | Chief Executive Officer | 21 Aug 2024 | Sale | 3,674 | 12.2453 | 44,989 | D |
22 Aug 2024 17:15 | CNTA | Centessa Pharmaceuticals plc | SAHA SAURABH | Chief Executive Officer | 20 Aug 2024 | Sale | 4,169 | 12.3215 | 51,368 | D |
26 Mar 2024 16:16 | CNTA | Centessa Pharmaceuticals plc | ANDERSON KAREN M. | Chief People Officer | 25 Mar 2024 | Sale | 21,165 | 12.2058 | 258,336 | D |
26 Mar 2024 16:16 | CNTA | Centessa Pharmaceuticals plc | ANDERSON KAREN M. | Chief People Officer | 25 Mar 2024 | Sale | 29,995 | 11.6561 | 349,625 | D |
02 Feb 2024 17:03 | CNTA | Centessa Pharmaceuticals plc | ROTMAN HARRIS | SVP Regulatory Affairs | 01 Feb 2024 | Sale | 4,267 | 8.1027 | 34,574 | D |
22 Sep 2023 16:47 | CNTA | Centessa Pharmaceuticals plc | ROTMAN HARRIS | SVP Regulatory Affairs | 20 Sep 2023 | Sale | 37,484 | 6.2877 | 235,688 | D |
02 Jun 2023 17:01 | CNTA | Centessa Pharmaceuticals plc | YVER ANTOINE | EVP & Chairman of Development | 01 Jun 2023 | Sale | 6,500 | 4.4537 | 28,949 | D |
26 May 2023 17:01 | CNTA | Centessa Pharmaceuticals plc | BUSH TIA L | Chief Quality Officer | 24 May 2023 | Sale | 3,000 | 4.4801 | 13,440 | I |
26 May 2023 17:01 | CNTA | Centessa Pharmaceuticals plc | BUSH TIA L | Chief Quality Officer | 24 May 2023 | Sale | 5,000 | 4.485 | 22,425 | I |
02 May 2023 17:01 | CNTA | Centessa Pharmaceuticals plc | YVER ANTOINE | EVP & Chairman of Development | 01 May 2023 | Sale | 6,800 | 4.424 | 30,083 | D |
04 Apr 2023 17:03 | CNTA | Centessa Pharmaceuticals plc | YVER ANTOINE | EVP & Chairman of Development | 03 Apr 2023 | Sale | 6,700 | 3.691 | 24,730 | D |
03 Mar 2023 17:04 | CNTA | Centessa Pharmaceuticals plc | YVER ANTOINE | EVP & Chairman of Development | 01 Mar 2023 | Sale | 7,000 | 3.4243 | 23,970 | D |
03 Feb 2023 17:08 | CNTA | Centessa Pharmaceuticals plc | YVER ANTOINE | EVP & Chairman of Development | 01 Feb 2023 | Sale | 7,700 | 3.7923 | 29,201 | D |
04 Jan 2023 19:30 | CNTA | Centessa Pharmaceuticals plc | YVER ANTOINE | EVP & Chairman of Development | 04 Jan 2023 | Sale | 6,970 | 3.1759 | 22,136 | D |
05 Dec 2022 16:35 | CNTA | Centessa Pharmaceuticals plc | YVER ANTOINE | EVP & Chairman of Development | 01 Dec 2022 | Sale | 9,400 | 3.9089 | 36,744 | D |
23 Nov 2022 17:01 | CNTA | Centessa Pharmaceuticals plc | YVER ANTOINE | EVP & Chairman of Development | 03 Oct 2022 | Sale A | 9,500 | 3.9061 | 37,108 | D |
03 Nov 2022 16:49 | CNTA | Centessa Pharmaceuticals plc | YVER ANTOINE | EVP & Chairman of Development | 01 Nov 2022 | Sale | 9,700 | 4.0263 | 39,055 | D |
04 Oct 2022 17:07 | CNTA | Centessa Pharmaceuticals plc | CHAO DAVID M | Chief Administrative Officer | 03 Oct 2022 | Sale | 4,167 | 3.9501 | 16,460 | D |
04 Oct 2022 17:07 | CNTA | Centessa Pharmaceuticals plc | CHAO DAVID M | Chief Administrative Officer | 30 Sep 2022 | Sale | 3,401 | 4.0674 | 13,833 | D |
04 Oct 2022 17:06 | CNTA | Centessa Pharmaceuticals plc | TEMPLEMAN THOMAS | Chief Technology Officer | 03 Oct 2022 | Sale | 2,455 | 3.9501 | 9,697 | D |
04 Oct 2022 17:06 | CNTA | Centessa Pharmaceuticals plc | TEMPLEMAN THOMAS | Chief Technology Officer | 30 Sep 2022 | Sale | 2,003 | 4.0674 | 8,147 | D |
04 Oct 2022 17:04 | CNTA | Centessa Pharmaceuticals plc | GRAINGER DAVID J | Chief Innovation Officer | 03 Oct 2022 | Sale | 2,853 | 3.9501 | 11,270 | D |
04 Oct 2022 17:04 | CNTA | Centessa Pharmaceuticals plc | GRAINGER DAVID J | Chief Innovation Officer | 30 Sep 2022 | Sale | 2,328 | 4.0674 | 9,469 | D |
04 Oct 2022 17:02 | CNTA | Centessa Pharmaceuticals plc | WEINHOFF GREGORY M | Chief Financial Officer | 03 Oct 2022 | Sale | 4,901 | 3.9501 | 19,359 | D |
04 Oct 2022 17:02 | CNTA | Centessa Pharmaceuticals plc | WEINHOFF GREGORY M | Chief Financial Officer | 30 Sep 2022 | Sale | 4,000 | 4.0674 | 16,270 | D |
04 Oct 2022 16:59 | CNTA | Centessa Pharmaceuticals plc | YVER ANTOINE | EVP & Chairman of Development | 03 Oct 2022 | Sale | 12,524 | 3.9167 | 49,053 | D |
04 Oct 2022 16:59 | CNTA | Centessa Pharmaceuticals plc | YVER ANTOINE | EVP & Chairman of Development | 30 Sep 2022 | Sale | 2,468 | 4.0674 | 10,038 | D |
04 Oct 2022 16:57 | CNTA | Centessa Pharmaceuticals plc | HUSSAIN IQBAL J | General Counsel | 03 Oct 2022 | Sale | 4,563 | 3.9501 | 18,024 | D |
04 Oct 2022 16:57 | CNTA | Centessa Pharmaceuticals plc | HUSSAIN IQBAL J | General Counsel | 30 Sep 2022 | Sale | 3,725 | 4.0674 | 15,151 | D |
04 Oct 2022 16:55 | CNTA | Centessa Pharmaceuticals plc | SHAHIDI JAVAD | Chief Medical Officer | 03 Oct 2022 | Sale | 3,341 | 3.9501 | 13,197 | D |
04 Oct 2022 16:55 | CNTA | Centessa Pharmaceuticals plc | SHAHIDI JAVAD | Chief Medical Officer | 30 Sep 2022 | Sale | 2,727 | 4.0674 | 11,092 | D |
04 Oct 2022 16:52 | CNTA | Centessa Pharmaceuticals plc | BUSH TIA L | Chief Quality Officer | 03 Oct 2022 | Sale | 2,595 | 3.9501 | 10,251 | D |
04 Oct 2022 16:52 | CNTA | Centessa Pharmaceuticals plc | BUSH TIA L | Chief Quality Officer | 30 Sep 2022 | Sale | 2,118 | 4.0674 | 8,615 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)